Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Three-dimensional adult male head and skull contours.
Lee C, Loyd AM, Nightingale R, Myers BS, Damon A, Bass CR. Lee C, et al. Among authors: damon a. Traffic Inj Prev. 2014;15(4):402-6. doi: 10.1080/15389588.2013.822492. Traffic Inj Prev. 2014. PMID: 24471365
Thoracic and lumbar spinal impact tolerance.
Bass CR, Rafaels KA, Salzar RS, Carboni M, Kent RW, Lloyd MD, Lucas S, Meyerhoff K, Planchak C, Damon A, Bass GT. Bass CR, et al. Among authors: damon a. Accid Anal Prev. 2008 Mar;40(2):487-95. doi: 10.1016/j.aap.2007.08.006. Epub 2007 Sep 10. Accid Anal Prev. 2008. PMID: 18329398
Real-World Evaluation of Treatment Patterns and Clinical Outcomes among Patients With Chronic Myeloid Leukemia in Chronic Phase Treated With Asciminib in Clinical Practice in the United States: Real-world asciminib treatment outcomes in CML-CP.
Atallah EL, Wei D, Latremouille-Viau D, Rossi C, Damon A, Ferreira G, Guérin A, Jadhav K. Atallah EL, et al. Among authors: damon a. Clin Lymphoma Myeloma Leuk. 2024 Sep 26:S2152-2650(24)02357-7. doi: 10.1016/j.clml.2024.09.013. Online ahead of print. Clin Lymphoma Myeloma Leuk. 2024. PMID: 39426944
Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results.
Cortes JE, Sasaki K, Kim DW, Hughes TP, Etienne G, Mauro MJ, Hochhaus A, Lang F, Heinrich MC, Breccia M, Deininger M, Goh YT, Janssen JJWM, Talpaz M, de Soria VGG, le Coutre P, DeAngelo DJ, Damon A, Cacciatore S, Polydoros F, Agrawal N, Rea D. Cortes JE, et al. Among authors: damon a. Leukemia. 2024 Jul;38(7):1522-1533. doi: 10.1038/s41375-024-02278-8. Epub 2024 May 16. Leukemia. 2024. PMID: 38755421 Free PMC article. Clinical Trial.
136 results